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Regulated necrosis, termed necroptosis, is negatively regulated by caspase-8 and is dependent on the
kinase activity of RIPK1 and RIPK3. Necroptosis leads to rapid plasma membrane permeabilization and to
the release of cell contents and exposure of damage-associated molecular patterns (DAMPs). We are only
beginning to identify the necroptotic DAMPs, their modifications, and their potential role in the regulation
of inflammation. In this review, we discuss the physiological relevance of necroptosis and its role in themodu-
lation of inflammation. For example, during viral infection, RIPK3-mediated necroptosis acts as a backup
mechanism to clear pathogens. Necroptosis is also involved in apparently immunologically silent mainte-
nance of T cell homeostasis. In contrast, the induction of necroptosis in skin, intestine, systemic inflammatory
response syndrome, and ischemia reperfusion injury provoke a strong inflammatory response, which might
be triggered by emission of DAMPs from necroptotic cells, showing the detrimental side of necroptosis.Introduction
Necrosis has long been described as a consequence of extreme
physicochemical stress, such as heat, osmotic shock, mechan-
ical stress, and freeze-thawing, which kill cells quickly and
directly. Therefore, this cell death has been described as uncon-
trolled and accidental necrosis characterized by loss of plasma
membrane integrity and cellular collapse, though nuclei remain
largely intact during this process (Krysko et al., 2008a, 2008b;
Vanden Berghe et al., 2010). Loss of membrane integrity and
release of intracellular content grant necrotic cells the ability to
induce an inflammatory response. These immunogenic endoge-
nous molecules fall under the umbrella term ‘‘damage-associ-
ated molecular patterns’’ (DAMPs) (Garg et al., 2010; Krysko
et al., 2011). They include, in the case of accidental necrosis,
HMGB1, IL-1a, uric acid, DNA fragments, mitochondrial content,
and ATP (Tables 1 and 2) (Eigenbrod et al., 2008; Kono et al.,
2010; Krysko et al., 2008a; Sauter et al., 2000). Because the
nomenclature of DAMPs in the literature is confusing, here we
define DAMPs as a family of molecules that are intracellular in
physiological conditions and can be divided into two groups:
(1) molecules that perform noninflammatory functions in living
cells (such as HMGB1, ATP) and acquire immunomodulatory
properties when released, secreted, modified, or exposed on
the cell surface during cellular stress, damage, or injury (Rock
and Kono, 2008), or (2) alarmins, i.e., molecules that possess
cytokine-like functions (such as IL-1a and IL-33), which can be
stored in cells and released upon cell lysis, whereupon they
contribute to the inflammatory response (Oppenheim and
Yang, 2005) (Tables 1 and 2). Several DAMPs have been shown
to stimulate pattern-recognition receptors (PRRs) (Chen and
Nun˜ez, 2010) (Table 1). The PRR family consists of Toll-like
receptors (TLRs), RIG-I-like receptors (RLRs), nucleotide-
binding domain and leucine-rich repeat containing molecules
(NLRs), and C-type lectin receptors (CLRs) (Takeuchi and Akira,
2010). PRRs are initial sensors of infection that coordinate theinflammatory response to diseased cells and therefore mediate
pathogen elimination. Often, the same receptors recognize
both DAMPs and pathogen-associated molecular patterns
(PAMPs), indicating the similarities between pathogen-induced
responses and inflammatory responses to cell stress, injury, or
death (Table 2).
Different cellular stimuli (e.g., TNF, Fas ligand, TRAIL ligand,
double-stranded RNA (dsRNA), interferon-g (IFN-g), ATP deple-
tion, ischemia-reperfusion injury, and pathogens) have been
shown to induce necrosis that follows defined steps and
signaling events reminiscent of a cell-death program (Vanlange-
nakker et al., 2012). This regulated necrosis, also named necrop-
tosis, can be defined as cell death mediated through a pathway
that depends on the receptor-interacting protein kinase 1
(RIPK1)-RIPK3 complex (Figure 1) and that can be inhibited by
Necrostatin-1 (Nec-1) (Galluzzi et al., 2012). RIP3K can also
form complexes with DNA-dependent activator of interferon
regulatory factor (DAI) and the adaptor molecule TRIF (TIR-
domain-containing adaptor-inducing interferon-b; adaptor
protein downstream of TLR3), leading to RIP3K-dependent pro-
grammed necrosis (Mocarski et al., 2012). However, these defi-
nitions should be interpreted carefully. First, there is no unique
biochemical marker for necroptosis. Necroptotic cell death
in vitro is confirmed by plasma membrane rupture and by lack
of specific apoptotic markers such as caspase activation and
chromatin condensation. Second, it has also become clear
that RIPK1 kinase activity can participate in apoptosis induction
in conditions of cIAP (cellular inhibitors of apoptosis proteins)
depletion or inhibition, which can result in FADD-RIPK1-
caspase-8 ripoptosome complex formation and Nec-1-inhibited
apoptosis (Feoktistova et al., 2011; Tenev et al., 2011).
Necroptosis can be triggered by members of the tumor
necrosis factor (TNF) family (e.g., TNF) (Vercammen et al.,
1997), Toll-like receptors (TLR3 and TLR4) (Chan et al., 2003;
Holler et al., 2000; Laster et al., 1988), and DNA and/or RNAImmunity 38, February 21, 2013 ª2013 Elsevier Inc. 209
Table 1. Necrotic DAMPs, PAMPs, and Their Receptors
Receptor Adaptor PAMPs DAMPs
TLRs
TLR2 Myd88 Lipoprotein HMGB1, HSPs
TLR3
(endosomal)
TRIF Viral, bacterial
DNA
Ribonucleoproteins,
mRNA
TLR4 Myd88/TRIF LPS HMGB1, HMGN1,
HSPs Hyaluronan
Biglycan Heparin
sulfate
TLR6 Myd88 Diacyl
lipoprotein
U1 snRNP
TLR7
(endosomal)
Myd88 Viral/bacterial
ssRNA
U1 snRNP
TLR9
(endosomal)
Myd88 Viral/bacterial
DNA
mtDNA HMGB1
RNA or DNA sensors
RIG-I MAVS dsRNA dsRNA
DAI TBK1 dsDNA dsDNA
DAMPs or alarmins-specific receptors
CD14/CD40/
CD91
TLR4 cofactor/
TRAF6
HSPs/GP96
CD24 Siglec HMGB1 HSPs
RAGE Myd88 HMGB1 S100B
DNGR-1 F-actin
P2Y P2X ATP
IL1R1 Myd88 IL1a
ST2L/ IL1RAcP Myd88 IL33
Numerous DAMPs released from cells undergoing accidental necrotic
cell death have been described. DAMPs and PAMPs can be recognized
by the same group of PRRs. TLRs recruit downstream the MyD88
adaptor (myeloid differentiation protein), except for TLR3, which signals
through the TRIF adaptor. DNA or RNA sensors can also recognize
bacterial, viral, or self-nucleic acid. Additionally, several other receptors
that do not recognize specific PAMPs (CD24 and P2X/Y receptors, IL-
1R) have also been reported to interact with DAMPs released from acci-
dentally necrotic cells.
Abbreviations are as follows: Myd88-Myeloid differentiation primary
response gene (88); TRIF, TIR-domain containing adaptor-inducing
IFN-b; MAVS, mitochondrial antiviral signaling protein; TBKA, TANK-
binding kinase 1; ST2L, IL-1 receptor-like 1; IL1RAcP, IL-1 receptor
accessory protein.
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triggered apoptosis is mediated by caspases, TNF-facilitated
necroptosis requires inhibition of caspase-8 and assembly of
RIPK1-RIPK3 complex IIb, also called the necrosome (Vandena-
beele et al., 2010). Additionally, after TNF triggering, RIPK1
ubiquitylation controls the switching between prosurvival
signaling and apoptotic and/or necroptotic cell death (Figure 1).
Briefly, after the ligand binds to TNFR1, two complexes with
opposing signaling can be formed. The prosurvival complex,
‘‘complex I,’’ containing TRADD, TRAF2/5, RIPK1, IAPs, and
LUBAC (Haas et al., 2009), initiates the activation of NF-kB,
JNK, and p38 MAPKs. This complex, which is highly ubiquity-
lated, remains associated with the TNFR1 receptor (Bertrand
et al., 2008). In contrast, endosomal internalization of TNFR1 is210 Immunity 38, February 21, 2013 ª2013 Elsevier Inc.accompanied by the release of the receptor-associated com-
plex from TNFR1 and the recruitment of FADD and procas-
pase-8, resulting in formation of complex IIa (Figure 1). Complex
II is of two types; complex IIa can trigger apoptosis, whereas
complex IIb, also called necrosome, initiates necroptosis.
Complex IIa and complex IIb are highly regulated by c-FLIPS,
FLIPL, or viral inhibitors (vICA, CrmA, E8, etc.). When recruitment
of procaspase-8 is prevented (c-FLIPS), caspase-8 is inhibited
(CrmA) or genetically deleted, RIPK1 and RIPK3 accumulate
and become phosphorylated, leading to increased necrosome
formation and consequently to necroptosis. The recruitment
of RIPK3 to RIPK1 occurs through a homotypic interaction
domain (RHIM), followed by the mutual phosphorylation of
RIPK1 and RIPK3 (Sudan et al., 2009; Zhang et al., 2009).
What determines the switch from complex IIa to IIb is not clear.
The switch requires the activity of the deubiquitylating enzyme
CYLD (O’Donnell et al., 2011) and it is facilitated by inhibition
or absence of caspase-8 (Kaiser et al., 2011; Oberst et al.,
2011). The activity of the NAD-dependent deacetylating enzyme
SIRT2 (Narayan et al., 2012) has been implicated in the RIPK1-
mediated recruitment of RIPK3 and the formation of complex
IIb (Figure 1). Mixed lineage kinase like protein (MLKL) and
the mitochondrial phosphatase 5 (PGAM5) are other RIPK3-
interacting proteins that are crucial for necroptosis induction
(Zhao et al., 2012). Therefore, we could define the TNF necrop-
totic pathway as a process that involves the positive action of
CYLD, RIPK1, RIPK3, SIRT2, and MLKL and negative regulation
by caspase-8 and IAPs.
Interestingly, besides RIPK1’s role in the decision of the cell’s
life or death, it has been proposed as one of the possible regula-
tors of the release of cytokines and alarmins in necroptotic cells
(Christofferson et al., 2012). The kinase activity of RIPK1 medi-
ates the production of TNF, which might contribute to cell death
and inflammation (Christofferson et al., 2012) and might function
as an alarmin in myocardial injury (Gallucci andMatzinger, 2001).
It has also been shown in vitro that necroptotic material is coin-
gested with the extracellular fluid by antigen-presenting cells
(APCs) via macropinocytosis (Krysko et al., 2006), which occurs
only after loss ofmembrane integrity (Brouckaert et al., 2004) and
with slower kinetics than uptake of apoptotic cells. This implies
that necroptotic cells could release more DAMPs than apoptotic
cells, in which potential DAMPs are restrained by the preserved
plasma membrane and apoptotic bodies. Most studies on
DAMPs have been devoted to DAMPs that are released during
accidental cell death (Table 2) and by secondary necrotic cells
following apoptosis. Relatively few studies have investigated
whether necroptosis is accompanied by release of a distinct
set of DAMPs and the roles of these DAMPs in necroptosis-
induced inflammation. In this review, we focus on necroptosis
induced by pathogens (bacteria and viruses) and discuss the
immunological consequences of these interactions, including
release of DAMPs. We also discuss the role of necroptosis and
the associated DAMPs in the induction of inflammation, for
example in skin, intestine, systemic inflammatory response
syndrome (SIRS), and ischemia reperfusion injury. In this
scenario, necroptosis-induced inflammatory diseases can be
seen as sterile process in genetically deficient mouse models.
So the inflammation can be attributed (at least partially) to the
release of DAMPs. However, this sterile situation differs from
Table 2. Immunological Consequences of Accidental Necrotic Cell Death In Vitro and In Vivo
Cell line Necrosis induction Model
DAMPs
or Alarmins Immunological Outcome Reference
In vitro
HeLa (A) ionomycin
(B) CCCP
(C) deoxy-glucose
and sodium azide
(D) 3 cycles of
freeze/ thaw (F/T)
Coculture with bone
marrow macrophages
(BMDM)
HMGB1 [TNF (Scaffidi et al., 2002)
THP-1, U-937 6 cycles F(LN)/ T Coculture with THP-1 HMGB1
and HSP70
[TNF, IL-6, IL-8 (El Mezayen et al., 2007)
Human neutrophils,
murine thymocytes,
human tumor
cell line
5 cycles of F/T Coculture with LPS-
activated macrophages
ND Necrotic neutrophils
but no other cells Y TNF,
IL-6, IL-1b and IL-8 from
LPS- activated macrophages
(Miles et al., 2009)
KS24.22 primary
breast tumor cells
F (LN)/ T Coculture with mDCs
and T cell activation
assay
ND Phagocytosis but no T cell
activation measured as
IFN-g production
(Inzkirweli et al., 2007)
11Ba/F3 cells F/T Coculture with resident
peritoneal macrophages
and i.p. injection
ND Lack of IL-1b production,
lack of recruitment of
neutrophils to the site
of injection
(Ayna et al., 2012)
T24 F/T Coculture with hDCs ND Lack of DCs maturation (Garg et al., 2012)
DO11.10 murine
T cells
HS 55C for 25 min Coculture with LPS-
activated RAW 264.7
macrophages cell line
ND Lack of NF-kB activation,
Lack of TNF and IL-6
modulation
(Cvetanovic and
Ucker, 2004)
In vivo
Bone marrow
derived dendritic
cells (BMDCs)
5 cycles F/T Injection into the
peritoneal cavities
IL-1a Infiltration of neutrophils
into peritoneum,
CXCL1 secretion
(Eigenbrod et al., 2008)
B16 cells (A) pressure disruption
(B) F/T
Injection into the
peritoneal cavities
ATP (A) neutrophil influx,
Nlrp3 dependent IL-1a
production only
(B) no effect of F/T
necrotic cells
(Iyer et al., 2009)
BD7 keratinocytes hypoxic conditions Injection into the
peritoneal cavities
IL1-a Infiltration of leukocytes (Rider et al., 2011)
Renal cells Histones-induced
necrosis
Histones injection into
renal artery of mice
Histone 4
TLR2, TLR4
dependent
neutrophil infiltration, [ IL-6,
TNF, and inducible nitric
oxide synthase
(Allam et al., 2012)
B16, L5178Y-ML25
lymphoma
(A) heat-killed
(B) formalde-
hyde fixed
(C) F/T
Tumor vaccination
model
ND Only (A) but not (B) or (C):
stimulation of APCs,
[ IL-12 and TNF; effective
anti-tumor vaccine
(Yoon et al., 2008)
CT26, B16, L5178Y,
SP815
(A) 4 cycles
(B) F/T
(C) osmotic shock
Tumor vaccination
model
ND (A), (B), (C) lack of protective
immune response in tumor
vaccination model
(Goldszmid et al., 2003),
(Bartholomae et al., 2004;
Scheffer et al., 2003)
Abbreviations are as follows: LN, liquid nitrogen; F/T, freeze/thaw; DC, dendritic cells (m, murine, h, human); ND, not defined; APC, antigen presenting
cells; HS, heat shock.
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Reviewinfectious processes, in which infection-induced apoptosis or
necroptosis can become immunogenic as a result of the simulta-
neous engagement of PAMPs and DAMPs with PRR.
Necroptosis and DAMPs Release during Bacterial
Infection
Recognition of pathogens through PRRs is the first line of
defense against microbial infections. Although most pathogenscan activate apoptotic or pyroptotic (inflammasome-mediated)
cell death through TLRs or NLRs, some PAMPs and DAMPs in
particular cell types and conditions may be associated with
necroptosis induction in vitro and in vivo (Figure 2A). In this
respect, it has been shown that stimulation of TLR3 by dsRNA
(poly[I:C]) or TLR4 by LPS in combination with caspase inhibition
leads to RIPK3-mediated necroptosis in murine macrophages
(He et al., 2011) and FADD-deficient Jurkat cells (Kalai et al.,Immunity 38, February 21, 2013 ª2013 Elsevier Inc. 211
Figure 1. Overview of Ripoptosome Formation in Response to Different Stimuli
Necroptosis can be induced by various stimuli that are recognized by specific receptors. After TNF binds its receptor, TNFR1-mediated signaling can lead to cell
survival (a), apoptosis (b), or necroptosis (c). For FasL and TRAIL stimulation, caspase-8 activation occurs at the internalized receptor complex, called death
inducing signaling complex (DISC), whereas TNF signaling initially forms a receptor associated complex (complex I), followed by a cytosolic complex IIa (b) and
complex IIb (c). Stable complex IIb, also called necrosome, is formed in some cellular conditions such as presence of RIPK3 or reduced caspase-8 activity in
which RIPK3 is recruited to RIPK1 allowing mutual phosphorylation (c). Cytosolic FADD-RIPK1-caspase-8 complex (further referred to as ripoptosome), can also
be formed following stimulation of T cell receptor, TLR3 or TLR4, as well as in response to genotoxic stress. In the latter case, the ripoptosome activates
apoptosis, but it cannot be ruled out that in specific conditions of caspase-8 inactivation, it can also induce necrosome formation (dashed arrow). T cell
proliferation following antigen activation requires caspase-8 activation by the CARMA1-BCL-10-MALT1 complex leading to NF-kB activation. However, when
caspase-8 is genetically deleted or inhibited, CYLD (as a substrate of MALT1) probably accumulates, leading to sensitization of necroptotic signaling in T cells
when RIPK3 is present and the necrosome complex is formed (d). Additionally, TRIF (adaptor of TLR3 and TLR4) can recruit RIPK1, which in turn can recruit RIPK3
via the homotypic interaction motif (RHIM), thereby bridging TLR signaling to the necrosome (e). RIPK1 can also mediate proinflammatory signaling by activating
the transcription factor NF-kB or AP-1-SP1 (f). Cytoplasmic (DAI-I, RIG-I, and MDA5) and endosomal sensors (TLR3, TLR7-8, and TLR9) of nucleic acids activate
IRFs and NF-kB, which leads to the production of IFN-b involved in antiviral response (f). RIG-I and MDA5, through the homotypic CARD interaction domain,
recruit the MAVS adaptor on mitochondria, which can further bind RIPK1 and possibly enable recruitment of RIPK3 (dashed arrows). In contrast, DAI-I contains
a RHIM domain by which RIPK1 and RIPK3 can be recruited and a necrosome is formed (g).The ripoptosome is also formed after TLR4 stimulation by LPS in DCs
lacking caspase-8 (h), which contains the pronecroptotic molecules RIPK1 and RIPK3, as well as MLKL and PGAM5. However, this ripoptosome, instead of
mediating cell death, contributes to NALPR3 inflammsome formation and activation, leading to pro-IL1b production and its processing into active proin-
flammatory cytokine IL-1.
DRs, death receptors; MDA5, melanoma differentiation-associated protein 5; RIG-I, retinoic acid-inducible gene 1; INF, interferon; ds, double-stranded, ss,
single-stranded; TRIF, TIR domain-containing adaptor-inducing INF-b; MAVS (IPS-1), mitochondrial antiviral-signaling protein; MLKL, mixed lineage kinase
domain-like protein; PGAM5, phosphoglyceratemutase 5.
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Review2002). Interestingly, the TLR4 signaling pathway is involved in
HMGB1 secretion from macrophages by a mechanism that
depends on interleukin-1 (IL-1) receptor-associated kinase 4
(IRAK4) (Wang et al., 2010), suggesting that HMGB1 might
be released during TLR4-mediated necroptosis. Furthermore,212 Immunity 38, February 21, 2013 ª2013 Elsevier Inc.when TLR3 is engaged, TRIF interacts with RIPK3 through the
RHIM domain; this leads to ROS production and necroptosis
(He et al., 2011). Moreover, TLR3-agonist can sensitize HaCaT
and HeLa cells to RIPK1- and RIPK3-dependent necroptosis in
the absence of cIAPs and inhibition of caspases (Feoktistova
Figure 2. Pathogen-Mediated Necroptosis and Possible Modifications of DAMPs
(A) Stimulation of necroptosis by bacterial PAMPs. Bacterial products can stimulate TLR3 and 4 (also possibly TLR9, dashed arrow) to trigger necroptotic cell
death when caspase-8 is inhibited or genetically ablated. Additionally, stimulation of TLRs and NLRs by PAMPs can provoke inflammatory responses in infected
cells (a) and interferons production (b). DuringS. typhimurium infection, IFN type I receptor (IFNR) engages RIPK1, leading to recruitment of RIPK3 and necrosome
formation (c). Binding of IFNs to IFNR activates the JAK-STAT pathway (d) leading to IFNs production and upregulation ofRipk1 and possibly alsoHmgb1, thereby
providing RIPK1molecules for necroptosome formation (e) and resulting in HMGB1 release from dying cells. PRRs can discriminate between PAMPs and DAMPs
through CD24-SiglacG/10 signaling. CD24 receptor and SiglecG/10 can bind to DAMPs but not to PAMPs. This brings CD24-SiglacG/10 close to TLR, which
becomes desensitized for PAMP triggering by the action of a phosphatase (SHP-1) (f). DAMPs and PAMPs become indistinguishable during infection due to
removal of sialic acid residues from CD24 and both trigger inflammation (a).
(B) Stimulation of necroptosis by viral infection. Viral inhibitors of caspase-8 are produced by many viruses (e.g. caspase-8 inhibitors: CrmA, vICA, BORFE2;
cFLIP homologs: E8, K13, MA159) and effectively block apoptosis. The absence of active caspase-8 sensitizes an alternative cell death pathway: necroptosis (g).
However, viral protein M45 has been shown to prevent ripoptosome formation by binding to the RHIM domain of RIPK3, inhibiting necroptosis and inflammation
(k). Additionally, viral proteins such as NS1 and A52R have been shown to blunt PRRs signaling by inhibiting the binding and sequestration of nucleic acids. Until
now, RIPK1-RIPK3-dependent necroptosis has only been observed in response to MCMV and VV viruses; and most likely, ripoptosome formation involves TLR3
signaling and TRIF–RIPK1-RIPK3 interaction (i). The cytosolic sensor of foreign DNA- DAI -directly engages RIPK1 and RIPK3 in RHIM-dependent complexes and
drives the assembly a ripoptosome (j).
(C) Release of DAMPs during necroptosis and their potential modifications. Many DAMPs released from accidental necrotic cells have been described (Table 2),
but no specific necroptotic DAMPs have been identified. So far, several DAMPs have been associated with necroptotic conditions (C; Table 3). Also, nuclei
containing HMGB1, cytokines, long genomic DNA, and histones have been observed in necrotic tissues. Damagedmitochondria (and insufficient mitophagy) are
source of ROS production, mitochondrial DNA (mtDNA), and other mitochondrial molecules. Additionally, absence of caspase activation during necroptosis
might modify the properties of the released DAMPs as compared to apoptosis. Caspase activity was reported to induce high levels of ROS production during
apoptosis, resulting in the oxidation of HMGB1 and leading to the production of its immunologically silent form. However, oxidation of two free cysteines of
HMGB1 to a disulfide bond by ROS during necroptosis can lead to generation of the proinflammatory form of HMGB1. Activity of caspase-8 leads also to
production of CRT, an ‘‘eat-me’’ signal. Caspase-3 and -7 can process full-length proinflammatory IL-33 (IL-33FL) into an inactive form. Absence of caspases,
which are necessary for DNA fragmentation, might induce the release of long genomic DNA (LG DNA). Caspases also participate in the generation of the ‘‘find-
me’’ signal, LPC, by cleavage of PLA2. Lack of PLA2 cleavage might prevent the release of ‘‘find-me’’ signals from necroptotic cells. Additionally, the ER-
associated molecule PERK is involved in the release of the ‘‘eat-me’’ signals ATP and CRT, which we speculate can be abrogated during necroptosis.
MCMV, murine cytomegalovirus; vICA, viral inhibitor of caspase activation; vFLIPs, viral FLIPs; CrmA, cytokine response modifier A; E3- caspase-8 inhibitor,
adenovirus; BORFE2, caspase-8 inhibitor, BHV-4 virus; HMGB1, high mobility group box 1 protein; NLRs, NOD-like receptors; ROS, reactive oxygen species;
PLA2, phospholipase A2; CAD, caspase-activated DNase; ICAD, inhibitor of caspase activated DNase, LMP, lysosomal membrane permeabilization.
Immunity 38, February 21, 2013 ª2013 Elsevier Inc. 213
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Reviewet al., 2011). In addition, stimulation of TLR9 by unmethylated
CpG triggers caspase-independent cell death of pro-B cells
(Lalanne et al., 2010). However, whether TLR9-induced cell
death involves RIPK1 and RIPK3 remains to be examined.
TLR-mediated necroptosis could also be induced in vivo and
might lead to inflammation. Injection of wild-type (WT) mice
with LPS or poly(I:C) combined with zVAD-fmk, a pan-caspase
inhibitor, leads to necroptotic cell death of macrophages and
increases serum concentrations of pro-inflammatory cytokines
(IL-6, TNF, MCP-1, IFN-g) (He et al., 2011). Death of macro-
phages and circulating cytokine amounts were both markedly
inhibited when LPS and zVAD-fmk or poly(I:C) and zVAD-fmk
was injected into RIPK3-deficient mice or dominant-negative
mutant TrifLPS2/LPS2 mice, pointing to the involvement of RIPK3
and TRIF in TLR-mediated necroptosis (He et al., 2011).
Although the above-mentioned studies were conducted using
synthetic ligands or bacterial products to stimulate TLRs, several
models of bacterial infections have also been shown to induce
necroptosis in host immune and nonmyeloid cells in vitro.
Epithelial cells infected with Shigella die by necrosis, as deter-
mined by double propidium iodide and Annexin V positivity
and absence of TUNEL-positive staining (Carneiro et al., 2009).
This cell death could not be inhibited by zVAD-fmk, and it was
accompanied by the secretion of KC (a neutrophil-attracting
chemokine) into the supernatant of infected mouse embryonic
fibroblasts (MEF). It has been shown that the a-toxins of
Clostridium septicum (Morinaga et al., 2010) and Legionella
pneumophila (Kennedy et al., 2009) induce necrotic-like cell
death in macrophages andmyoblasts, respectively. Importantly,
in both studies the authors showed that necrotic cell death was
associated with the release of HMGB1 (Figure 2). Further studies
are required to analyze whether this type of caspase-indepen-
dent cell death induced by bacteria (Kennedy et al., 2009;
Morinaga et al., 2010) is dependent on RIPK1 and/or RIPK3
and therefore could be considered as necroptosis. RIPK1-
and/or RIPK3-dependent necroptosis is observed during
Salmonella typhimurium infection (Figure 2A). In vitro and in vivo
analysis showed that Salmonella induces type I interferon-
dependent assembly of RIPK1 and/or RIPK3, leading to necrop-
tosis of macrophages accompanied by release of proinflamma-
tory cytokines such as TNF, KC, IL-1a and IL-1b, and IFN-g
(Robinson et al., 2012). This cell death was not due to endoge-
nous TNF production or TNFR1 stimulation, suggesting that
type I IFN can engage the necroptosis pathway independently
of TNF (Robinson et al., 2012). No DAMPs were analyzed in
this study, but another group (Kim et al., 2009) investigated the
role of the IFN-b signaling pathway in HMGB1 release and found
that the IFN-b and JAK-STAT signaling pathways are critical for
HMBG1 release during stimulation of TLR4 by E. coli (Kim et al.,
2009). These observations collectively show that bacterial infec-
tion could activate TLRs and lead to production of IFNs, which in
an autocrine or paracrine way could activate the necroptotic
pathway and contribute to HMBG1 release (Figure 2A) (Robinson
et al., 2012).
It is important to know whether these in vitro studies can be
extrapolated to the in vivo situation and to understand whether
the released HMGB1 (and very likely also other DAMPs) could
contribute to the inflammatory response instigated by the
necroptosis induced by PAMP and bacteria. Whether microbial214 Immunity 38, February 21, 2013 ª2013 Elsevier Inc.infections can modify the immunological responses to DAMPs
should also be investigated (Figure 2). The crosstalk between
PAMP and DAMP recognition and signaling could be an impor-
tant issue in the etiology of sepsis (SIRS), asthma, inflammatory
bowel disease, and autoimmune diseases. Indeed, organs such
as skin, intestine, and lungs are constantly exposed to both
commensals and pathogens, so they are more vulnerable to
conditions of danger and/or damage and permanent microbial
stimulation.
TheDAMP-PAMP crosstalk is regulated by theCD24-SiglecG/
10 axis (Chen et al., 2009), which determines whether or not
the TLRs and/or NLRs associated with CD24 will induce
inflammation when exposed to DAMPs (Chen et al., 2011)
(Figure 2A). Siglec-G/10 belongs to a family of immunoglob-
ulin-like lectins that can recognize sialic-acid-containing struc-
tures present on CD24. Moreover, DAMPs such as HMGB1,
HSP70, and HSP90 interact directly with CD24 (Chen et al.,
2009), and the DAMPs-CD24-Siglec G/10 complex enables
phosphatases such as SHP-1 to repress TLR and NLR signaling.
Interestingly, the sialylation status of CD24 determines whether
or not the DAMP repression system will operate. Indeed, several
microbes and viruses possess sialidases as a virulence factor
(Chan et al., 2012). Removal of sialic acid residues from CD24
prevents the formation of the DAMP-CD24-Siglec-G/10
complex, resulting in increased inflammatory responses to
TLRs and NLRs during PAMP and DAMPs stimulation. This
mechanism may explain the increased inflammation in diseases
associated with bacterial stimulation, such as sepsis (SIRS).
Recent studies revealed that bacterial sialidases promote
inflammation in the cecal ligation and puncture (CLP) model of
sepsis. Elevated levels of sialidases lead to decreased binding
of CD24 with Siglec G/10, increasing the interaction between
TLRs and DAMPs (Chen et al., 2011). Moreover, stimulation of
macrophages with TNF and LPS can activate the host’s cyto-
plasmic sialidases (Gee et al., 2003), and TNF-induced SIRS
has been associated with RIPK3-mediated necroptosis (Duprez
et al., 2011). Therefore, the host’s endogenous sialidases
released during necroptotic cell death together with bacterial
sialidases could sensitize TLRs and NLRs to DAMPs and lead
to exacerbation of inflammation in sepsis (SIRS).
Viruses: Master Regulators of Cell Death and DAMPs
Release?
Viral spread depends on the fate of infected cells. The interac-
tions between viruses and eukaryotic cells have led to selection
of eukaryotic genes that propagate cell death upon infection to
block viral multiplication, while some viruses encode suppres-
sors of cell death to counteract these protective mechanisms.
Viruses suppress not only the apoptotic pathway but also the
necroptotic pathway, demonstrating that both programmed
cell death mechanisms are crucial for host defense (Figure 2B).
Caspase-8 is essential for T cell proliferation after antigen
stimulation (Ch’en et al., 2008) and for CD4+ and CD8+ T cell-
mediated antiviral responses (Duttagupta et al., 2009). Interest-
ingly, viruses have evolved into having many specific caspase-
8 inhibitors, such as cytokine response modifier A (CrmA), viral
inhibitor of caspase activation (v-ICA), and viral FLICE-like
inhibitory proteins (FLIPs) (Mocarski et al., 2012). Here, we
come to a paradoxical function of caspase-8. Initially, it was
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tion of apoptosis to allow the virus to propagate in the infected
cell. However, recently it became clear that caspase-8, FLIPL,
and FADD negatively control necroptosis induction, probably
by cleaving RIPK1, RIPK3, and CYLD (Dillon et al., 2012;
O’Donnell et al., 2011) or some other target(s) downstream of
RIP3 kinase. This would mean that on the one hand inhibition
of caspase-8 prevents apoptosis induction while on the other
hand the cell would be sensitized to necroptosis induction. But
why would viruses paradoxically activate an alternative cell
death program? For the virus, this could be a way to control its
own pathogenicity or to modulate the release of DAMPs. For
the host, necroptosis can be viewed as a ‘‘trap door’’ that opens
when caspase-8 is inhibited and it is involved in host defense
(Mocarski et al., 2012). In this regard, evaluation of RIP3K-
deficient mice has shown that necroptosis plays an important
role in the control of vaccinia virus (VV) (Cho et al., 2009) but is
dispensable for the control of WT murine cytomegalovirus
(MCMV) (Upton et al., 2010), mouse hepatitis virus (Lu et al.,
2011a), and lymphocytic choriomeningitis virus (LCMV) (Ch’en
et al., 2011), arguing for case-specific strategies in host-virus
immune responses. Infection of WT mice with VV induces tissue
necroptosis and infiltration of neutrophils into visceral fat pads,
but these events are significantly decreased in RIPK3-deficient
animals (Cho et al., 2009). This reduced inflammation correlated
with increased viral titers in the organs of RIPK3-deficient mice,
and consequently, these mice were more vulnerable to the
infection. This indicates that RIPK3 is required for protection
against VV (Cho et al., 2009). Conspicuously, the authors
reported that the inflammatory foci were concentrated in areas
of extensive necroptosis in WT mice, which could indicate emis-
sion of DAMPs from necroptotic cells. Indeed, virus infection can
be accompanied by emission of DAMPs such as Hsp70 and
HMGB1 (Lietze´n et al., 2011; Wheeler et al., 2009). However,
again as a result of coevolutionary selection, some viruses can
‘‘switch off’’ the emission of DAMPs or blunt the interaction
of TLRs with DAMPs and/or PAMPs to prevent an immune
reaction. For example, protein A52R expressed by VV inhibits
the signaling mediated by TLR2, 4, and 9, West Nile virus
(WNV) nonstructural protein 1 (NS1) inhibits TLR3 signaling,
and other viral proteins sequester virus dsRNA (Aravalli et al.,
2008; Bowie and Unterholzner, 2008) (Figure 2B).
Some viruses (e.g., MCMV) have evolved strategies to
counteract several death pathways. MCMV encodes both an
inhibitor of caspase-8 (Skaletskaya et al., 2001) and a RIPK3
inhibitor (Upton et al., 2010), and so it can efficiently block
both apoptosis and necroptosis. Activation of regulated necrosis
is a mechanism for combating MCMV in the absence of cas-
pase-8 activity. Upton et al. showed that MCMV-induced
RIPK3-dependent programmed necrosis is amajor host defense
pathway that can be effectively blocked by the viral RIPK3
inhibitor, M45 (Figure 2B). This protein possesses a homotypic
interaction domain RHIM, which enables it to bind RIPK3.
Consequently, MCMV can efficiently block necroptosis, but
strains lacking M45 or containing a mutation in its RHIM domain
induce regulated necrosis that is dependent on RIPK3 but not on
RIPK1 (Kaiser et al., 2011; Upton et al., 2010). But through which
receptor-adaptor system do viruses engage host RIPK3-medi-
ated necroptosis? Recently, DNA-dependent activator of IRFs(DAI) was identified as an essential partner of RIPK3 in MCMV-
induced programmed necrosis in vitro and in vivo (Upton et al.,
2012). This study strongly suggests that DAI functions as
a PRR in the pathway of RIPK3-dependent necroptosis induced
by MCMV.
Several other viruses, including WNV, HIV type 1 (HIV-1), and
herpes simplex virus (HSV), have been shown to induce necrotic-
like cell death. Although these viruses have not been evaluated in
RIP3K-deficient mice, cells infected in vitro with WNV develop
a necrotic morphology followed by HMGB1 release (Chu and
Ng, 2003). HIV-1-infected T cell lines, in the presence of the
caspase inhibitor zVAD-fmk, undergo necrotic-like, mitochon-
dria-dependent cell death (Petit et al., 2002). HSV type 1
(HSV-1) can inhibit apoptosis and elicit necroptosis in vitro; this
cell death could be partially blocked by the RIPK1 kinase
inhibitor Nec-1 and cathepsin inhibitors (Peri et al., 2011). Addi-
tionally, dengue virus (DV) induces either apoptotic or necrotic
cell death, depending on the virus titer. Interestingly, infection
with DV causes translocation of HMGB1 from the nucleus to
the cytoplasm and its active secretion from live infected cells
and passive release from dying cells (Chen et al., 2008; Kamau
et al., 2009; Ong et al., 2012). The amount of HMGB1 in the extra-
cellular environment increased and was correlated with higher
multiplicity of infection and a shift from apoptotic to necrotic
cell death (Ong et al., 2012). Ong et al. reported that active
release of HMGB1 is mediated by virus capsid protein, which
triggers acetylation and secretion of HMGB1. Once in the
extracellular milieu, HMGB1 acts on endothelial cells, induces
vascular leakage, and increases the risk of development of
dengue shock syndrome (Ong et al., 2012). In addition, elevated
levels of the proinflammatory cytokines TNF and IL-6 were
observed upon infection (Kamau et al., 2009). However, it is
unclear whether these phenomena at higher virus titers are due
to necroptosis, because the involvement of RIPK1 and/or
RIPK3 was not analyzed in these studies. Necrotic morphology
could be easily mistaken for secondary necrosis, especially
that the type of cell death could often depend on virus titer
(Chu and Ng, 2003). More work is required to identify DAMPs
emitted from virus-induced necroptotic cells and to understand
their roles in induction of inflammation.
The FADD-Caspase-8 Platform and Autophagy as
Mechanisms to Regulate Necroptosis in T Cells
Several reports indicate that necroptosis could regulate T cell
number in peripheral tissues during T cell development. Mice
lacking caspase-8 or mice expressing mutant FADD unable to
recruit caspase-8 (FADD DED deficient, FADDdd) (Lu et al.,
2011b) in T cells had fewer CD4+ and CD8+T cells in the
periphery, and this was correlated with excessive cell death
(Salmena et al., 2003). Concomitant research in double deficient
caspase-8-RIPK3 and FADDdd-RIPK3 T cells revealed accumu-
lation of excessive and abnormal lymphocytes (lymphadenop-
athy) in these mice, indicating that RIPK3-driven necroptosis is
responsible for clearance of these lymphocytes during their
development (Ch’en et al., 2011; Kaiser et al., 2011). Additionally,
necroptosis has been implicated in the elimination of excessive
T cells after activation (contraction of lymphocytes). Removal
of activated T lymphocytes that had undergone clonal expansion
in response to stimulation (infection) is essential for maintenanceImmunity 38, February 21, 2013 ª2013 Elsevier Inc. 215
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immunodeficiency or autoimmunity. Defective expansion of
T cells after TCR activation was observed in T cells deficient in
caspase-8 (Ch’en et al., 2011; Salmena et al., 2003) or FADD
(Osborn et al., 2010) as well as in FADDdd-expressing T cells
(Lu et al., 2011b). It has been proposed that the inability of
T cells to accumulate after activation was due to extensive cell
death. Indeed, Osborn et al. used Nec1 to inhibit RIPK1 activity
and discovered that the proliferative capacity of FADD-deficient
T cells was restored when the RIPK1 kinase activity was abol-
ished. Moreover, these authors suggested that RIPK1-driven
necroptosis might occur naturally during the T cell development
because Nec1 treatment enabled wild-type T cells to proliferate
with a higher rate than the control cells (Osborn et al., 2010).
Similarly, the T cell accumulation defect of caspase-8 deficient
and FADDdd expressing T cells was restored by RIPK3 deletion
(Lu et al., 2011a), indicating that necroptosis can be activated
when active capase-8 is not available, leading to T cell depletion
in response to stimulation.Mice lacking caspase-8 or expressing
FADDdd in T cells are also unable to mount a proper immune
response when infected with murine hepatitis virus (MHV),
because these cells lack cytotoxic activity. However, additional
deletion of RIPK3 in both cases restored the proper immune
responses. Therefore, it seems that when caspase-8 is absent,
RIPK3-mediated necroptosis promotes death of ‘‘immunologi-
cally useless’’ T cells unable to mount proper immune responses
to pathogens. However, in physiological conditions the FADD-
caspase-8 platform acts to prevent necroptosis because
caspase-8- and FADD-deficiency leads to the embryonic death
of mice, which can be rescue by ablation of RIPK3 (Dillon et al.,
2012; Kaiser et al., 2011). In this respect, to the best of our
knowledge the only instance in which caspase-8 could be
naturally inhibited would be during infection by a virus encoding
caspase inhibitors, as discussed above. However, it is also
conceivable that in other pathological conditions FADD and/or
caspase-8 could be downregulated revealing necroptotic
signaling.
Also other mechanisms, such as autophagy, may control the
sensitivity to necroptosis (Bray et al., 2012). T lymphocyte prolif-
eration is impaired in the absence of Atg5, Atg7, Atg3, or Beclin-1
(He et al., 2012). Interestingly, RIPK1 has been proposed to be
a linker between necroptotic cell death and autophagy in acti-
vated T cells. A hyperautophagic phenotype has been observed
in FADDdd- and caspase-8-deficient lymphocytes after TCR
stimulation (Bell et al., 2008; Ch’en et al., 2008). Treatment with
Nec1 in these models not only prevented cell death but appar-
ently also reduced the extent of autophagy. However, these
results should be interpreted carefully because conflicting find-
ings have been reported on autophagy and its crosstalk with
apoptosis and necroptosis (Long and Ryan, 2012). Another
aspect of the regulation of necroptosis by autophagy deals
with the important role of mitophagy in removing damaged mito-
chondria (Youle and Narendra, 2011), because they are an
important source of ROS, which contributes to necroptosis.
Indeed, interference with the mechanism responsible for the
removal of damaged mitochondria could sensitize for necropto-
sis. We have discussed this sensitization of necroptotic cell
death by CrmA overexpression already in 1998: ‘‘Elimination of
such deficient but oxygen radical-producing mitochondria216 Immunity 38, February 21, 2013 ª2013 Elsevier Inc.should then be beneficial for the cell to survive the deadly TNF
signal’’ (Vercammen et al., 1998). The molecular mechanisms
of this interplay between mitophagy and necroptosis are
currently investigated. In that respect, Wang et al. recently
showed a connection between RIPK3 kinase activity and the
MLKL platform, which recruits complex IIb to mitochondria.
This interaction results in mitochondrial fission and fragmenta-
tion (Wang et al., 2012). Taken together, decreased mitophagy
and increased rupture of mitochondria may enable the release
of mitochondrial DNA (or mitochondrial proteins) that serve as
DAMPs and promote ROS production, whichmay act as DAMPs
modifiers.
The Silent and Proinflammatory Faces of Necroptosis
It is well established that apoptotic cell death can switch to
necroptosis under certain conditions. However, the effect of
necroptotic cell death on immune responses in vitro and in vivo
has been barely studied. Necroptotic material can be coingested
in vitro by endocytosis-macropinocytosis (Krysko et al., 2003;
Krysko et al., 2006). Vesicles containing necroptotic material
might deliver DAMPs to APCs to initiate an immune response.
However, L929 cells subjected to TNF-induced necroptosis do
not induce proinflammatory cytokine production in macro-
phages. This mouse fibrosarcoma cell line is commonly used
as an in vitro model of necroptosis (Vanden Berghe et al.,
2010; Vanlangenakker et al., 2011). Similarly, B16 mouse mela-
noma cells, in which necroptosis was triggered by inducible
expression of FADD-death domain, were unable to induce
maturation of dendritic cells (DCs) (Lohmann et al., 2009). These
observations can be interpreted in twoways: either coincubation
of necroptotic cells withmacrophages does not reflect the proin-
flammatory capacity of necropotic cells or necroptotic cells
poses anti-inflammatory properties in vitro. On the other hand,
investigation of necroptotic cell death in mouse models
discloses the proinflammatory face of this cell death mode. Cer-
ulein-induced acute pancreatitis resulted in necroptotic cell
death of pancreas accompanied by overexpression of RIPK3
in pancreas but not in other organs (Sudan et al., 2009). Further
evidence linking RIPK1 and RIPK3-mediated necroptosis
with inflammation arose from studies on mice with FADD and
caspase-8 deficiency in keratinocytes. Mice with epidermis-
specific FADD deletion developed skin inflammation due to
spontaneous necroptosis of keratinocytes and intense release
of HMGB1; this was not observed in animals double-deficient
in FADD and RIPK3, demonstrating an important role of
RIPK3-dependant necroptosis in inflammation (Bonnet et al.,
2011). Studies on FADD-TNFR1 and FADD-MyD88 deficiency
revealed that both TNF and TLR signaling partially contribute
to progression of inflammation. TNF produced in response to
TLR-driven MyD88 signaling amplify TNF induced necroptosis,
whereas excessive HMGB1 observed in epidermis of FADD-
deficient mice acts as a DAMP that triggers inflammation
through TLRs (Bonnet et al., 2011). A similar phenotype of skin
inflammation was reported in mice lacking caspase-8 in
keratinocytes. Although the involvement of necroptosis was
not investigated in this model, these authors observed upregula-
tion of DAMPs such as S100a9 and IL-33 (Kovalenko et al.,
2009), which could indicate the involvement of increased
necroptosis in inflammation.
Table 3. Necroptotic DAMPs in Transgenic Mice and Inflammatory Disease Models
Cell Type Mouse Model Necroptosis Immune Response DAMPs References
Epidermal
keratinocytes
Caspase-8
deletion
ND Skin inflammation [ S100a9, IL-33 (Kovalenko et al., 2009;
Li et al., 2010)
Epidermal
keratinocytes
FADD deletion RIPK3 mediated Skin inflammation ND but MyD88 deficiency
delayed onset of
inflammation
(Bonnet et al., 2011)
Intestinal
Epithelial Cells
Caspase-8
deletion
RIPK1/RIPK3
mediated
Spontaneous ileitis;
susceptibility to
experimental colitis
ND (Gu¨nther et al., 2011)
Intestinal
Epithelial Cells
FADD deletion RIPK3/CYLD
mediated
Chronic intestinal
inflammation
ND but MyD88 deficiency
partially protected from
colon inflammation
(Welz et al., 2011)
Disease Mode of Induction Necroptosis Immune Response DAMPs References
SIRS TNF induced RIPK1/RIPK3
mediated
Systemic inflammation,
[ IL-1a, IL-6 and damage
markers (HEX, LDH, AST,
ALT, CK)
Presence of mtDNA
in serum
(Duprez et al., 2011)
SIRS Trauma patients ND Systemic inflammation,
[ IL-6, IL-8, TNF
Presence of mtDNA
in serum
(Zhang et al., 2010)
Neonatal
Brain Injury
Hypoxia–ischemia RIPK1/RIPK3
mediated
Brain damage, [ IL-1b,
IL-6, IL-12p35, and TNF
ND but TLR2 deficiency
partially prevented brain
damage
(Northington et al., 2011)
(Rosenbaum et al., 2010;
Stridh et al., 2011)
Kidney Ischemia
Reperfusion
Ischemia RIPK1 mediated Kidney damage,
[ circulating damage
markers (urea, creatinine)
HMGB1-TLR4 mediated
inflammation
(Linkermann et al., 2012)
(Wu et al., 2010)
Myocardial
Ischemia
Ischemia RIPK1/MLKL
mediated
Neutrophils and
macrophages influx,
[ LDH and ROS
ND but TLR4 deficiency
protects from myocardial I/R
(Oerlemans et al., 2012)
(Fallach et al., 2010)
Abbreviations are as follows: ND, not defined; HEX, hexosaminidase; LDH, lactate dehydrogenase; AST, aspartate transaminase; ALT, alanine trans-
aminase; CK, creatine kinase; ROS, reactive oxygen species.
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in the gut were described 30 years ago in patients with
Crohn’s disease (Dourmashkin et al., 1983). Only recently,
necroptosis of Paneth cells in the terminal ileum was connected
with the pathogenesis of inflammatory bowel disease. Samples
collected from patients showed strong RIPK3 expression
(Gu¨nther et al., 2011), suggesting that necroptosis can contri-
bute to the development of inflammatory disorders. Specific
deletion of FADD (Welz et al., 2011) or caspase-8 (Bonnet
et al., 2011; Gu¨nther et al., 2011) in intestinal epithelial cells
(IECs) induces chronic inflammation characterized by extensive
epithelial cell death. Double-deficient FADD-RIPK3 mice
showed no signs of inflammation, and high levels of RIPK1
and RIPK3 messenger RNA (mRNA) were observed in the intes-
tine of caspase-8-deficient mice, suggesting that cell death in
the epithelium may be due to necroptosis. Interestingly, in
both cases of intestinal inflammation, Paneth cells were fewer
or absent, suggesting that this cell type might be highly suscep-
tible to necroptosis. Gu¨nther et al. (2011) showed that caspase-
8-deficient Paneth cells are sensitive to RIPK1-RIPK3-mediated
necroptosis, leading to decreased expression of antimicrobial
peptides and sensitizing terminal ileum and colon to inflamma-
tion. Similarly, Welz et al. showed that FADD-deficient Paneth
cells are susceptible to RIPK3-mediated necroptosis and that
their production of antimicrobial peptides is impaired. Addition-
ally, colon of mice lacking both FADD and MyD88 are at leastpartially protected from inflammation, suggesting that TLR stim-
ulation can accelerate inflammation (Welz et al., 2011) (Table 3).
As already mentioned, the implication of TLR could be partially
due to stimulation of TNFR1 by TNF, which is produced in
response to TLR-driven MyD88 signaling. In this regard, ileal
biopsies from control patients showed Paneth cell loss in the
presence of high levels of exogenous TNF, but this was revers-
ible by coincubation with necrostatin-1 (Gu¨nther et al., 2011).
Therefore, TNF-induced necroptosis of Paneth cells might be
one of the key events in the pathogenesis of intestinal bowel
diseases.
In a totally different context, but illustrating the effects of nec-
roptotic cell death on the innate immune system, it was recently
shown that RIPK3-dependent necroptosis causes mortality in
mice subjected to experimental TNF-induced systemic inflam-
matory response syndrome (SIRS) and CLP- induced peritoneal
sepsis (Duprez et al., 2011). Release of mitochondrial DAMPs
(Krysko et al., 2011) such as mitochondrial DNA (mtDNA) into
plasma and necroptotic cell death were reduced in RIPK3
knockout mice. Duprez et al. (2011) proposed that a combination
of several DAMPs released by necroptotic cells in this model
might synergistically trigger sustained cytokine release and
amplify the inflammatory response. Indeed, mtDNA can activate
TLR9 and was identified as amajor DAMP contributing to inflam-
matory responses in trauma patients developing sepsis (clinical
SIRS) (Zhang et al., 2010).Immunity 38, February 21, 2013 ª2013 Elsevier Inc. 217
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organ failure has also been observed in models of ischemia-
reperfusion (IR). Linkermann et al. showed that RIPK1-mediated
necroptosis occurs during kidney ischemia-reperfusion injury
and that it can be rescued by Nec-1 inhibitor (Linkermann
et al., 2012). Similarly, increased phosphorylation of RIPK1 and
RIPK3was observed duringmyocardial IR, and Nec-1 prevented
necroptotic cell death and inflammation (infiltration of neutro-
phils) (Oerlemans et al., 2012). In addition, it has been shown
that necroptosis contributes to neuronal damage in a retina IR
model (Rosenbaum et al., 2010) and in neonatal brain injury
(Chavez-Valdez et al., 2012). Interestingly, it has been proposed
that TLR signaling contributes to the severity of inflammation in
IR models, suggesting that inflammation in IR models could be
mediated at least partially by DAMPs. In this regard, it has
been shown that TLR4 mediates exacerbation of kidney IR via
HMGB1 (Wu et al., 2010) and that TLR4 deficiency reduces
myocardial IR (Oyama et al., 2004).
All these data strongly suggest that in vivo necroptosis is asso-
ciated with an inflammatory reaction (Table 3). However, there is
only limited knowledge of the molecular mechanisms involved
and the role of the proinflammatory DAMPs emitted during
necroptosis. Both RIPK1 and RIPK3 are required for necroptosis
initiation (Figure 1), but necroptosis can also occur in the
absence of RIPK1 (Upton et al., 2010; Zhang et al., 2009).
Therefore, it seems that RIPK3 drives necroptosis whereas
RIPK1 is involved in specific cellular contexts. Recent studies
emphasize that it is RIPK3, through its ability to induce ROS
formation, rather than necroptosis itself, that propagates
immune responses or inflammasome activation (Vince et al.,
2012; Wallach et al., 2011). Moreover, RIPK3 expression
depends on the cell type. Expression of RIPK3mRNA is stronger
in lymphocytes, monocytes, and natural killer cells than in other
cell types (BioGps, http://biogps.org). Hence, it is possible that
only limited types of cells undergo necroptosis in normal condi-
tions. But in pathological conditions, enhanced RIPK3 expres-
sion could mediate the switch from apoptotic to necroptotic
cell death and exacerbate inflammation. On the other hand,
a recent discovery (Kang et al., 2012) sheds new light on inflam-
matory diseases in transgenic mice lacking caspase-8. As
discussed above, restriction of caspase-8 is associated with
skin and intestinal inflammation and excessive activation of
RIPK1 and RIPK3, which are involved in necroptosis. Therefore,
inflammation observed in these transgenic mice has been asso-
ciated with proinflammatory DAMPs released during this cell
death. However, lack of caspase-8 apparently also strongly
activates the NLRP3 inflammasome in LPS-stimulated DCs,
leading to excessive production of IL-1b. This inflammasome
activation depends probably on RIPK1-RIPK3 mediated mito-
chondrial ROS production (Vince et al., 2012, Kang et al.,
2012), as mentioned above. Surprisingly, although this proin-
flammatory pathway involved signaling proteins engaged in initi-
ation of necroptosis, inflammasome activation occurred inde-
pendently of necroptosis. Therefore mortality and inflammation
(as evaluated by increased levels of IL-1b and TNF in serum)
observed in transgenic mice lacking caspase-8 in DCs occur
probably independently of necroptosis. Taken together, these
data point to important crosstalk between necroptosis, inflam-
mation, and DAMPs. This crosstalk could occur either in the218 Immunity 38, February 21, 2013 ª2013 Elsevier Inc.same cells, but it cannot be ruled out that different cells or cell
types contribute by proinflammatory cytokine production
through activation of the inflammasome, whereas other cells or
cell types contribute to DAMP release through the initiation of
necroptosis. At a certain point, both inflammasome activation
and necroptosis initiation mutually affect the inflammatory
outcome. Altogether, these studies again place caspase-8 in
a central position as an important brake on inflammation that
acts either by controlling inflammasome activation or by control-
ling necroptosis.
Distinct Biochemical Pathways of Apoptosis and
Necroptosis Lead to Different DAMPs Signatures
DAMPs can originate from any compartment of injured or
damaged cells, including plasma membrane, cytosol, nucleus,
ER, and mitochondria. Distinct biochemical processes occur
during apoptosis and necroptosis. In apoptosis we see caspase
activation, chromatin condensation, nuclear fragmentation, DNA
cleavage, contained apoptotic bodies, extracellular caspases,
and rapid and efficient phagocytosis (Vanden Berghe et al.,
2010). In necroptosis we observe no massive caspase activa-
tion, no chromatin condensation, intact nuclei, spillage of cell
content, phagocytosis by macropinocytosis, lysosomal leakage,
and an oxidative burst (Vanden Berghe et al., 2010). Therefore,
the compositions and signatures of apoptotic and necroptotic
DAMPs might be qualitatively and quantitatively different.
Because caspases are intimately engaged in apoptosis,
absence of their activity during necroptosis might modulate
the immunogenicity of released DAMPs (Martin et al., 2012)
(Figure 2C). In apoptosis, caspases cleave phospholipase A2
(PLA2) to produce the ‘‘find-me’’ signal lysophatidylcholine
(LPC), which enables phagocytosis (Lauber et al., 2003), and
caspase-activated DNase (called CAD) is responsible for inter-
nucleosmal cleavage of genomic DNA, whichmight have weaker
immunostimulatory properties than high molecular weight DNA
(Martin et al., 2012). In addition, full-length IL-33 is released
during necrosis, but during apoptosis it can undergo caspase-
dependent proteolysis into a nonimmunological form (Lu¨thi
et al., 2009). Therefore, full-length IL-33 released in necroptotic
conditions (Kovalenko et al., 2009) (when caspases are not
active) could be one of the necroptotic DAMPs (Figure 2C). Cas-
pase activity is also thought to be responsible for modification of
the immunogenic DAMP, HMGB1, into the nonimmunogenic
oxidized HMGB1 form, and caspase-dependent condensation
of chromatin traps HMBG1 during apoptosis (Kazama et al.,
2008; Taylor et al., 2008). Furthermore, active caspase-8 is an
important mediator of the emission of DAMPs, such as calreticu-
lin (CRT) (Panaretakis et al., 2009), that function as an ‘‘eat me’’
signal for DCs and is required for immunogenic responses in
antitumor treatment (Krysko et al., 2012). However, in most of
the research conducted on necroptosis, caspase-8 was inacti-
vated by chemical inhibition or genetic deletion. Therefore, it is
important to point out that this ablation of caspase-8 in experi-
mental conditions on the one hand sensitizes cells or mouse
models to necroptosis, but on the other hand it might also restrict
or at least modify the emission of DAMPs during necroptosis.
Additionally, mitochondria play an important role in necrop-
totic cell death (Vandenabeele et al., 2010) and DAMPs release
(Krysko et al., 2012). Insufficient autophagy of these deteriorated
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mtDNA and possibly other mitochondrial proteins (Oka et al.,
2012). On the other hand, damaged mitochondria are an impor-
tant source of ROS that not only contribute to progression of cell
death but can also modify the oxidative status of DAMPs.
HMGB1 can illustrate this redox sensitivity (Figure 2C). This
molecule can become proinflammatory in its reduced form
(associated with necrosis) and immunologically silent in its
oxidized form, which requires caspase activation and ROS
production (Kazama et al., 2008). HMGB1 lacks a leader peptide
for the classical ER-Golgi secretory pathway, so it resides in cells
in reduced form. Moreover, two mutually exclusive forms of
HMGB1 exert two different functions: disulfide-HMGB1 (oxida-
tion of C23-C45) acts through TLR4 to induce cytokine produc-
tion, whereas all-thiol-HMGB1 (all cysteines reduced) acts on the
CXCR4 receptor to induce immune cell migration (Venereau
et al., 2012). Therefore, the redox status contributes to both
attraction of immune cells and inflammation. Next to the role of
mitochondria in DAMPs release and modification, other
biochemical processes activated possibly simultaneously with
or regulating necroptosis, such as ER-stress could also affect
the quality and quantity of released DAMPs. For example,
PKR-like endoplasmic reticulum kinase (PERK) is necessary for
the emission of two important DAMPs, CRT and ATP (Garg
et al., 2012), which facilitate the uptake of dying cells by APCs.
However, the PERK pathway can be inactivated by PERK’s
pseudosubstrates or viral inhibitory proteins resembling the
way by which caspase-8 is inactivated (Galluzzi et al., 2012). In
these conditions, CRT and ATP would not be emitted and dying
virus-infected cells would not induce the activation of APCs.
Although these possibilities have not been investigated, we
speculate that also proteins of ER-stress pathway could
modulate necroptosis and necroptotic DAMPs. Additionally,
organelles retained inside apoptotic bodies can be released or
externalized during necrosis or necroptosis. For example, intact
nuclei have been detected during necroptosis in the extracellular
milieu (Krysko et al., 2003) and in tissues (Welz et al., 2011). Such
nuclei may contain many nuclear DAMPs, such as IL-1a (Luheshi
et al., 2009), IL-33 (Carriere et al., 2007), HMGB1 (Thomas and
Stott, 2012) and largely intact genomic DNA. Other differential
features of necroptosis are lysosomal membrane permeabiliza-
tion (LMP) (Vanden Berghe et al., 2010) and absence of transla-
tional inhibition. Because necroptotic cells continue to synthe-
size proteins until the last moment before plasma membrane
permeabilization (Saelens et al., 2005), a necroptotic environ-
ment is expected to be enriched in DAMPs, and proteins could
be modified during the cell death process by oxidation or by
lysosomal cathepsin-dependent proteolysis (Figure 2C). In this
regard, it has been shown that necroptotic cells secrete the
proinflammatory cytokine IL-6 (Vanden Berghe et al., 2006),
which could then function as an alarmin. Therefore, the
processes activated during the different cell death types may
profoundly affect the composition and properties of released
DAMPs, and it is clear that DAMPs are important, but their mech-
anisms of action are poorly understood.
Concluding Remarks
The previous decade brought new insights into necroptotic cell
death as a programmed and actively regulated process.Because necroptosis is associated with rapid plasmamembrane
permeabilization, DAMPs are probably released from these
cells, after which they perform immunomodulatory functions in
the intracellular milieu. However, many unanswered questions
and controversies still surround both necroptosis and DAMPs.
The necroptotic pathway can only operate under specific
conditions and is tightly controlled. Indeed, the caspase-8-
FLIPL-FADD platform and autophagy are apparently gate
keepers preventing necroptosis under physiological conditions.
Moreover, caspase-8 or FADD deficiency is the only condition in
which TCR-induced necroptosis can be observed. Furthermore,
experimental necroptosis-induced sterile inflammation also
requires inhibition or genetic ablation of caspase-8 (skin and
intestinal inflammation models). Therefore, besides these strict
conditions of caspase-8 inactivation or ablation, what could be
the role of necroptosis in physiological conditions? It has been
proposed that necroptosis plays a role during development,
but RIPK3-deficient mice are viable and they do not display
any obvious developmental defects. Additionally, FADD- or
caspase-8 deficient mice die as embryos at the stage of
vascular, cardiac, and hematopoietic development; this can be
rescued by RIPK3 deletion. This observation suggests the
importance of FADD-caspase-8 axis in development and indi-
cates that necroptosis might act as a mechanism for eliminating
defective organisms.
The function of necroptosis in the regulation of activated
T cells is controversial. T cells lacking caspase-8 in a C57BL/6
genetic context do not accumulate defective lymphocytes,
whereas caspase-8 deficient T cells in a mixed 129/C57BL/6
background develop lymphoproliferative disease (Salmena and
Hakem, 2005), indicating that the genetic background may
determine the efficacy of necroptosis in the T cell compartment.
A similar lymphoproliferative disease is observed in patients
bearing a mutated variant of caspase-8 (Chun et al., 2002).
These patients accumulate abnormal lymphocytes, indicating
that necroptosis does not compensate for lack of apoptosis.
Although necroptosis has not been investigated in these
patients, it cannot be ruled out that functional caspase-10
present in humans (but not in mice) can take over the function
of defective caspase-8, suggesting that an additional antine-
croptotic mechanism may operate in humans.
According to current knowledge, ‘‘naturally occurring’’ nec-
roptosis is observed only in infectious pathological conditions.
Several bacterial and viral infections have been associated
with necroptosis and emission of DAMPs such as HMGB1.
The precise mechanism and the role of HMGB1 and other
DAMPs in infection-associated inflammation remain unknown.
First, most probably, multiple pathways, such as inflammasome
activation and pyroptosis induction by PAMPs during bacterial
or viral infection, can mediate and modify the release of
DAMPs and modulate in a paracrine way the PRRs on respond-
ing cells. Second, DAMPs released from necroptotic cells
can contribute to sensitization of necroptosis in neighboring
cells via induction of PRRs. Third, activation or modulation
of ER-stress, autophagy, and IFN signaling can modify the
properties of DAMPs. Especially viruses may subvert DAMPs
emission, because they not only inhibit caspase-8, making cells
more susceptible to necroptosis, but also produce viral proteins
that interfere with other multiple cellular pathways andImmunity 38, February 21, 2013 ª2013 Elsevier Inc. 219
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Reviewprocesses (such as TLRs signaling, caspases inhibition, ER
stress modulation).
Numerous DAMPs have been associated with accidental
necrosis, but it seems that the modes of necrosis induction as
well as the cell type affect the immunogenic outcome (Tables 1
and 2). Accordingly, several DAMPs (including HMGB1, S100
proteins, IL33, and mtDNA; Table 3) have been associated with
necroptosis-induced inflammatory diseases, but their roles in
immune responses remain to be investigated. It is also conceiv-
able that other cellular processes are simultaneously activated
with necroptosis such as autophagy/mitophagy, ER stress,
ROS production, and lysosomal leakage regulate the quality of
DAMPs in vivo. Therefore, it is of great importance to investigate
necroptotic DAMPs in their natural state because processes
such as oxidation and proteolysis could affect their immunolog-
ical properties.
Identification of new and/or specific necroptotic DAMPs will
help to identify and characterize new markers of necroptosis
and understand their roles in inflammatory diseases. Studying
the potential involvement of necroptosis in inflammatory disor-
ders is of particular interest because it will provide new targets
for clinical application and contribute to better treatment of infec-
tious and inflammatory diseases, and to development of
improved strategies for induction of immunogenic cell death in
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